Schneider Darren B, Dimuzio Paul J, Martin Niels D, Gordon Roy L, Wilson Mark W, Laberge Jeanne M, Kerlan Robert K, Eichler Charles M, Messina Louis M
Division of Vascular Surgery, University of California, San Francisco 94143-0222, USA.
J Vasc Surg. 2004 Oct;40(4):599-603. doi: 10.1016/j.jvs.2004.07.028.
Residual subclavian vein stenosis after thoracic outlet decompression in patients with venous thoracic outlet syndrome is often treated with postoperative percutaneous angioplasty (PTA). However, interval recurrent thrombosis before postoperative angioplasty is performed can be a vexing problem. Therefore we initiated a prospective trial at 2 referral institutions to evaluate the safety and efficacy of combined thoracic outlet decompression with intraoperative PTA performed in 1 stage.
Over 3 years 25 consecutive patients (16 women, 9 men; median age, 30 years) underwent treatment for venous thoracic outlet syndrome with a standard protocol at 2 institutions. Twenty-one patients (84%) underwent preoperative thrombolysis to treat axillosubclavian vein thrombosis. First-rib resection was performed through combined supraclavicular and infraclavicular incisions. Intraoperative venography and subclavian vein PTA were performed through a percutaneous basilic vein approach. Postoperative anticoagulation therapy was not used routinely. Venous duplex ultrasound scanning was performed postoperatively and at 1, 6, and 12 months.
Intraoperative venography enabled identification of residual subclavian vein stenosis in 16 patients (64%), and all underwent intraoperative PTA with 100% technical success. Postoperative duplex scans documented subclavian vein patency in 23 patients (92%). Complications included subclavian vein recurrent thrombosis in 2 patients (8%), and both underwent percutaneous mechanical thrombectomy, with restoration of patency in 1 patient. One-year primary and secondary patency rates were 92% and 96%, respectively, at life-table analysis.
Residual subclavian vein stenosis after operative thoracic outlet decompression is common in patients with venous thoracic outlet syndrome. Combination treatment with surgical thoracic outlet decompression and intraoperative PTA is a safe and effective means for identifying and treating residual subclavian vein stenosis. Moreover, intraoperative PTA may reduce the incidence of postoperative recurrent thrombosis and eliminate the need for venous stent placement or open venous repair.
静脉型胸廓出口综合征患者在胸廓出口减压术后残留的锁骨下静脉狭窄常采用术后经皮血管成形术(PTA)治疗。然而,在进行术后血管成形术前出现的间歇性复发性血栓形成可能是一个棘手的问题。因此,我们在2家转诊机构开展了一项前瞻性试验,以评估一期联合胸廓出口减压与术中PTA的安全性和有效性。
在3年时间里,25例连续患者(16例女性,9例男性;中位年龄30岁)在2家机构按照标准方案接受静脉型胸廓出口综合征治疗。21例患者(84%)接受了术前溶栓治疗腋锁骨下静脉血栓形成。通过锁骨上和锁骨下联合切口进行第一肋切除术。术中静脉造影和锁骨下静脉PTA通过经皮贵要静脉途径进行。术后未常规使用抗凝治疗。术后以及术后1、6和12个月进行静脉双功超声扫描。
术中静脉造影显示16例患者(64%)存在残留的锁骨下静脉狭窄,所有患者均接受了术中PTA,技术成功率达100%。术后双功扫描显示23例患者(92%)锁骨下静脉通畅。并发症包括2例患者(8%)出现锁骨下静脉复发性血栓形成,2例均接受了经皮机械性血栓切除术,其中1例恢复通畅。生存表分析显示,1年的初级和次级通畅率分别为92%和96%。
静脉型胸廓出口综合征患者手术胸廓出口减压术后残留锁骨下静脉狭窄很常见。手术胸廓出口减压与术中PTA联合治疗是识别和治疗残留锁骨下静脉狭窄的一种安全有效的方法。此外,术中PTA可能会降低术后复发性血栓形成的发生率,并消除放置静脉支架或进行开放性静脉修复的必要性。